ALNYLAM PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements

5 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated ALN-AT3 Global License Terms entered into as of April 8, 2019 by and between the Registrant and Genzyme Corporation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2019
ALN-AT3 Global License Terms entered into as of January 6, 2018 by and between the Registrant and Genzyme Corporation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
Exclusive License Agreement entered into as of January 6, 2018 by and between the Registrant and Genzyme Corporation
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2018
EXCLUSIVE LICENSE AGREEMENT FOR TUSCHL II UNITED STATES PATENTS AND PATENT APPLICATIONS
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2015
Ex-10.19 Co-exclusive License Agreement
License Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004